In the U.S., Hispanic women have been disproportionately affected by the HIV epidemic in recent years. Yet they’ve been less likely to take advantage of PrEP, a medication that significantly reduces the risk of getting HIV.
So we created a pilot intervention to inform more people about the medication by adding it to an existing and proven HIV-prevention program aimed at heterosexual Hispanic women. All of the participants in the pilot – none of whom previously were aware of PrEP – said they were satisfied with the intervention, and the vast majority learned a great deal. These results lead us to believe that this could be a good way to lower rates of HIV in the Hispanic community.
